Urinary excretion of IL-1β, IL-6 and IL-8 cytokines during relapse and remission of idiopathic nephrotic syndrome
Authors:
Open Access
- 1 January 2017
- journal article
- research article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 10, 1-5
Abstract
Background/aim: The role of pro-inflammatory cytokines in the immunopathogenesis of idiopathic nephrotic syndrome had been widely postulated. Reports on the release of cytokines, during idiopathic nephrotic syndrome (INS) activation, were conflicting in defining a specific interleukin pattern during relapse and remission of the disease. The aim of this study was to explore the role of IL-1β, IL-6 and IL-8 in the pathophysiology of INS during relapse and remission. Patients and methods: A total of 37 INS patients were included. Their demographic and biochemical data were reviewed. Levels of IL-1β, IL-6 and IL-8 were measured in the urine of patients during relapse and remission of the disease. Urine samples from 30 age- and sex-matched controls were checked for the same 3 cytokines. Results: Mean age of patients at study was 6.4 ± 3.2 years (range: 14 months–12 years). Male:female ratio was 24:13. Mean serum creatinine was 47 ± 13 µmol/L, and mean serum albumin was 21 ± 7 g/L. Mean urinary IL-1β, IL-6 and IL-8 levels, corrected to urinary creatinine, in patients during relapse were 132.94 ± 654.97, 217.82 ± 1124.31 and 150.227 ± 523.97 pg/µmol compared to 9.11 ± 40.75, 0.146 ± 0.652, and 6.455 ± 24.53 pg/µmol in controls, respectively (P = 0.02, 0.03 and 0.014, respectively). No significant difference was reported in the mean level of the 3 cytokines compared to controls during remission (P = 0.94, 0.092 and 0.076). Conclusion: Our results support the role of T-cell activation and the subsequent release of IL-1β, IL6 and IL8 in the pathogenesis of relapses in INS. The use of steroid-sparing cytokine blockers in managing relapses of INS remains a tempting challenge.Keywords
This publication has 27 references indexed in Scilit:
- The glomerular permeability factors in idiopathic nephrotic syndromePediatric Nephrology, 2015
- Role of basophils in the pathogenesis of minimal change nephrotic syndrome: A literature reviewExperimental and Therapeutic Medicine, 2014
- Regulatory and effector T cells changes in remission and resistant state of childhood nephrotic syndromeIndian Journal of Nephrology, 2014
- Glucocorticoid receptors, in vitro steroid sensitivity, and cytokine secretion in idiopathic nephrotic syndromeKidney International, 2004
- Expression of Functional CCR and CXCR Chemokine Receptors in PodocytesThe Journal of Immunology, 2002
- Cytokines and growth factors in renal diseaseNephrology Dialysis Transplantation, 1995
- A regulatory system for soluble immune response suppressor production in steroid-responsive nephrotic syndromeKidney International, 1990
- Suppression of immune responses to sheep erythrocytes by the lymphokine soluble immune response suppressor (SIRS) in vivo.The Journal of Immunology, 1986
- The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisoneThe Journal of Pediatrics, 1981
- PATHOGENESIS OF LIPOID NEPHROSIS: A DISORDER OF T-CELL FUNCTIONThe Lancet, 1974